• Live Coronavirus, last minute

  • Coronavirus The keys of pediatricians for going back to school with delta

Protection against

Covid-19

infections

in people who are fully vaccinated with

AstraZeneca

and

Pfizer

preparations

begins to decline within about six months, according to the findings of a study released Wednesday.

The results released today by experts in charge of the

Zoe Covid

investigation

revealed that the protection of the vaccine developed by Pfizer / BioNTech, which protected

88%

against the virus one month after the second dose was administered, decreased to

74%

between 5 and 6 months after the second injection.

In the case of the one developed by AstraZeneca, which offered

77%

protection against coronavirus infection one month after the second dose, the scientists saw that after four to five months of the vaccine that protection decreased to

67%

.

The study was carried out using Covid PCR test results that were positive, carried out between the last months of May and July among more than a

million people

in the

United Kingdom

who already had the complete immunization schedule.

In addition, the experts pointed out that in the worst case the protection provided by these vaccines against the virus could begin to decline to below 50% in the elderly and health workers for the winter.

Tim Spector,

the principal investigator of the Zoe Covid application, behind this analysis, believes that these results would explain the cases of infection registered in people with the full vaccination schedule.

"We should expect a decrease in protection (from vaccines) but this is not a reason for people not to get vaccinated," Spector said.

He also recalled that vaccines "continue to provide high levels of protection for the majority of the population, especially against the Delta variant, with which we continue to need to fully vaccinate as many people as possible."

The UK could start

offering a third

coronavirus

booster shot

next month to some people, although it has yet to get a recommendation from the independent body

JCVI,

which assesses that possibility.

However, Spector told the

BBC

that "many people may not need it" and considered that this matter needs to be "handled more carefully".

According to the criteria of The Trust Project

Know more

  • Coronavirus

  • AstraZeneca

  • Delta variant

  • United Kingdom

  • Vaccines

  • Covid 19

Covid-19 The father of the Oxford vaccine sees group immunity with the Delta variant as impossible

The WHO asks that the third dose of the coronavirus vaccines not be administered for now

Health How many vaccines have been given in Spain?

This is how vaccination against Covid-19 advances in each community

See links of interest

  • Last News

  • Work calendar

  • Home THE WORLD TODAY

  • Master Investigation Journalism

  • Direct afghanistan

  • Stage 11 of the Vuelta, live: Antequera - Valdepeñas